Latest News of EGP
AstraZeneca (LSE:AZN) Gains FDA Approval for Fasenra in EGPA, Boosting Revenue Growth and Market Position
AstraZeneca shows 18% revenue growth, upgraded guidance, and strong pipeline momentum. Challenges include rising costs and debt. Opportunities lie in innovative pipeline expansion and growth in emergi...
Investors in ikeGPS Group (NZSE:IKE) from three years ago are still down 53%, even after 17% gain this past week
The ikeGPS Group Limited (NZSE:IKE) share price rose by 29% in a quarter, but is still down by 53% over the last three years. The company's revenue growth has been strong, but lack of profits is a con...
ME Group International (LON:MEGP) Will Pay A Dividend Of £0.0345
ME Group International plc will pay a dividend of £0.0345 on November 29, with a 4.0% yield. While the dividend seems sustainable, the company's history of dividend instability raises concerns. With ...